Adjuvant chemotherapy with gemcitabine plus erlotinib vs. gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma: is there a role for erlotinib?-review of the open label phase III trial CONKO 005

Hepatobiliary Surg Nutr. 2018 Oct;7(5):399-402. doi: 10.21037/hbsn.2018.08.03.

Authors

Mathilde Wisniewski¹, Pierre-Alain Placide¹, Sandra Granier¹, Yacoub Al Shatti¹, Shuaib Al Qalaf¹, Mohamed Bouattour¹, Michele Lamuraglia¹, Pascal Hammel¹

Affiliation

¹ Department of Digestive and Medical Oncology, Hôpital Beaujon (AP-HP), University Denis Diderot-Paris VII, Clichy, France.

No abstract available

Publication types

Editorial
Comment